At a glance
ClinicalIndex Comparison RecordPhase 3Completed
Drug / intervention
enalaprildrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Studies of Left Ventricular Dysfunction (SOLVD)
National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Apr 15, 2016
In Brief
A Phase 3 clinical trial evaluating enalapril for Cardiovascular Diseases and 5 related conditions. Completed.
Detailed Summary
To determine if enalapril treatment of left ventricular dysfunction (LVD) due to ischemic or hypertensive heart disease led to reduced mortality and morbidity in symptomatic and asymptomatic patients. There were a Prevention Trial, a Treatment Trial, and a registry.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Coronary Disease, Heart Diseases, Heart Failure, Hypertension, Myocardial Ischemia
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
1985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 1985
Study CompletionMay 1990
First PostedOct 1999
TodayJul 2026
First PostedOct 28, 1999
Enrollment StartJul 1, 1985
Study CompletionMay 1, 1990
TodayJul 2, 2026
Posted 26.7 years ago
Interventions
enalaprildrug